Regeneron Pharmaceuticals Inc. buy Piper Sandler
Start price
01.11.24
/
50%
€780.20
Target price
01.11.25
€1,099.4
Performance (%)
-27.20%
End price
02.11.25
€568.00
Summary
This prediction ended on 02.11.25 with a price of €568.00. The prediction for Regeneron Pharmaceuticals Inc. disappointed with a performance of -27.20%. Piper_Sandler has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. A total of €2.60 was paid as dividends for this prediction. Piper_Sandler has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 2.860% | 2.860% | 23.339% |
| iShares Core DAX® | 4,57 % | 3,43 % | 8,17 % |
| iShares Nasdaq 100 | 1,83 % | -1,04 % | 34,66 % |
| iShares Nikkei 225® | -0,29 % | 3,38 % | 61,85 % |
| iShares S&P 500 | 2,23 % | 0,47 % | 25,07 % |
Comments by Piper_Sandler for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at Piper Sandler from $1,242.00 to $1,195.00. They now have an "overweight" rating on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€666.40
31.03.26
31.03.26
€762.30
31.03.27
31.03.27
-14.05%
03.07.26
03.07.26
Stopped prediction by Piper_Sandler for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€538.80
18.05.26
18.05.26
€735.81
18.05.27
18.05.27
6.30%
03.07.26
03.07.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€652.60
27.01.25
27.01.25
€964.27
27.01.26
27.01.26
-1.93%
28.01.26
28.01.26
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,072.0
23.08.24
23.08.24
€1,109.7
23.08.25
23.08.25
-53.25%
24.08.25
24.08.25